Manuel Morgado

1.7k total citations
44 papers, 1.2k citations indexed

About

Manuel Morgado is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Family Practice. According to data from OpenAlex, Manuel Morgado has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Geriatrics and Gerontology, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Family Practice. Recurrent topics in Manuel Morgado's work include Pharmaceutical Practices and Patient Outcomes (15 papers), Medication Adherence and Compliance (9 papers) and Blood Pressure and Hypertension Studies (8 papers). Manuel Morgado is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (15 papers), Medication Adherence and Compliance (9 papers) and Blood Pressure and Hypertension Studies (8 papers). Manuel Morgado collaborates with scholars based in Portugal, Spain and United States. Manuel Morgado's co-authors include Miguel Castelo-Branco, Elisa Cairrão, Ignácio Verde, António José Santos-Silva, Luísa Pereira, Paulo Magalhães, Mara Pereira Guerreiro, Gilberto Alves, Fátima Roque and Amílcar Falcão and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and Journal of Ethnopharmacology.

In The Last Decade

Manuel Morgado

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Morgado Portugal 16 357 281 275 206 146 44 1.2k
Bruno Michel France 14 168 0.5× 165 0.6× 41 0.1× 159 0.8× 80 0.5× 95 828
Elena Tragni Italy 21 118 0.3× 170 0.6× 105 0.4× 125 0.6× 197 1.3× 67 1.1k
Morten Hansen Denmark 17 216 0.6× 153 0.5× 87 0.3× 257 1.2× 420 2.9× 45 1.2k
Joseph Biskupiak United States 21 56 0.2× 360 1.3× 31 0.1× 155 0.8× 37 0.3× 85 1.5k
Federica Nicotra Italy 16 110 0.3× 487 1.7× 189 0.7× 101 0.5× 155 1.1× 21 1.5k
Arja Helin‐Salmivaara Finland 19 175 0.5× 285 1.0× 188 0.7× 78 0.4× 98 0.7× 37 1.4k
RJ Glynn United States 14 106 0.3× 355 1.3× 139 0.5× 104 0.5× 240 1.6× 20 1.4k
Ylva Böttiger Sweden 21 200 0.6× 79 0.3× 73 0.3× 195 0.9× 119 0.8× 53 1.4k
Michele M. Spence United States 13 143 0.4× 265 0.9× 78 0.3× 70 0.3× 151 1.0× 24 1.2k
Ana Filipa Macedo Portugal 14 177 0.5× 449 1.6× 85 0.3× 182 0.9× 460 3.2× 20 2.1k

Countries citing papers authored by Manuel Morgado

Since Specialization
Citations

This map shows the geographic impact of Manuel Morgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Morgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Morgado more than expected).

Fields of papers citing papers by Manuel Morgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Morgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Morgado. The network helps show where Manuel Morgado may publish in the future.

Co-authorship network of co-authors of Manuel Morgado

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Morgado. A scholar is included among the top collaborators of Manuel Morgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Morgado. Manuel Morgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plácido, Ana I., et al.. (2025). Understanding the Role of Irisin in Longevity and Aging: A Narrative Review. Epidemiologia. 6(1). 1–1. 2 indexed citations
2.
3.
Jesus, Mafalda, et al.. (2023). Active Pharmacovigilance Study: A Follow-Up Model of Oral Anti-Cancer Drugs under Additional Monitoring. Current Oncology. 30(4). 4139–4152. 2 indexed citations
4.
5.
Martins, Vera, Mafalda Jesus, Luísa Pereira, et al.. (2023). Hematological Events Potentially Associated with CDK4/6 Inhibitors: An Analysis from the European Spontaneous Adverse Event Reporting System. Pharmaceuticals. 16(10). 1340–1340. 3 indexed citations
6.
Plácido, Ana I., Fátima Roque, & Manuel Morgado. (2022). The Promising Role of Mushrooms as a Therapeutic Adjuvant of Conventional Cancer Therapies. SHILAP Revista de lepidopterología. 2(1). 58–68. 4 indexed citations
7.
Morgado, Manuel, et al.. (2020). Allergic rhinitis characterization in community pharmacy customers: a cross-sectional study. International Journal of Clinical Pharmacy. 43(1). 118–127. 3 indexed citations
8.
Plácido, Ana I., María Teresa Herdeiro, Manuel Morgado, Adolfo Figueiras, & Fátima Roque. (2020). Drug-related Problems in Home-dwelling Older Adults: A Systematic Review. Clinical Therapeutics. 42(4). 559–572.e14. 30 indexed citations
9.
Morgado, Manuel, et al.. (2020). Clinical pharmacists´ interventions in the management of type 2 diabetes mellitus: a systematic review. Pharmacy Practice. 18(3). 2000–2000. 22 indexed citations
10.
Plácido, Ana I., João Filipe Fernandes Lindo Simões, Odete Amaral, et al.. (2019). Daily Medication Management and Adherence in the Polymedicated Elderly: A Cross-Sectional Study in Portugal. International Journal of Environmental Research and Public Health. 17(1). 200–200. 40 indexed citations
11.
Morgado, Manuel, et al.. (2018). Arbutus unedo L.: From traditional medicine to potential uses in modern pharmacotherapy. Journal of Ethnopharmacology. 225. 90–102. 53 indexed citations
12.
Magalhães, Paulo, et al.. (2016). Trastuzumab in the Treatment of Breast Cancer. BioDrugs. 30(2). 75–86. 160 indexed citations
13.
Morgado, Manuel, et al.. (2012). Prescribing omissions in elderly patients admitted to a stroke unit: descriptive study using START criteria. International Journal of Clinical Pharmacy. 34(3). 481–489. 11 indexed citations
14.
Morgado, Manuel, et al.. (2011). Efficacy of Aliskiren/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Meta-Analytical Approach. The Open Cardiovascular Medicine Journal. 5(1). 6–14. 3 indexed citations
15.
Morgado, Manuel, Elisa Cairrão, António José Santos-Silva, & Ignácio Verde. (2011). Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. Cellular and Molecular Life Sciences. 69(2). 247–266. 144 indexed citations
16.
Morgado, Manuel, et al.. (2011). Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice. Journal of Cardiovascular Disease Research. 2(1). 44–49. 11 indexed citations
17.
Morgado, Manuel, et al.. (2011). Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. International Journal of Clinical Pharmacy. 33(1). 132–140. 114 indexed citations
18.
Morgado, Manuel, et al.. (2010). Blood pressure control and antihypertensive pharmacotherapy patterns in a hypertensive population of Eastern Central Region of Portugal. BMC Health Services Research. 10(1). 349–349. 8 indexed citations
19.
Macedo, Ana Filipa, et al.. (2010). Predictors of uncontrolled hypertension and antihypertensive medication nonadherence. Journal of Cardiovascular Disease Research. 1(4). 196–202. 81 indexed citations
20.
Santos-Silva, António José, Elisa Cairrão, Manuel Morgado, Ezequiel Álvarez, & Ignácio Verde. (2008). PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries. European Journal of Pharmacology. 582(1-3). 102–109. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Michel Breakdown of academic impact, for papers by Elena Tragni Breakdown of academic impact, for papers by Morten Hansen Breakdown of academic impact, for papers by Joseph Biskupiak Breakdown of academic impact, for papers by Federica Nicotra Breakdown of academic impact, for papers by Arja Helin‐Salmivaara Breakdown of academic impact, for papers by RJ Glynn Breakdown of academic impact, for papers by Ylva Böttiger Breakdown of academic impact, for papers by Michele M. Spence Breakdown of academic impact, for papers by Ana Filipa Macedo
Rankless by CCL
2026